Results 261 to 270 of about 86,728 (368)

Plant Acetyl-CoA Carboxylase: Structure, Biosynthesis, Regulation, and Gene Manipulation for Plant Breeding

Bioscience, biotechnology and biochemistry, 2004
Y. Sasaki, Y. Nagano
semanticscholar   +1 more source

Extracellular Vesicles in Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities

iNew Medicine, Volume 1, Issue 1, December 2025.
The role of extracellular vesicles (EVs) in the progression of nonalcoholic fatty liver disease (NAFLD). Donor cells release EVs containing various molecules such as cholesterol, ceramide, sphingomyelin, miRNA, DNA, proteins, and lipids. These EVs are taken up by multiple recipient cells including Kupffer cells, adipocytes, β cells, adipose tissue ...
Yunsheng Dong, Lei Xiong, Nina Zhu, Zihan Wang, Hanqi Xia, Chen Cheng, Jianshang Huang, Yiran Han, Abduxukur Rahman, Junhao Zhao, Chonggui Jiang, Li Zuo, Hua Wang   +12 more
wiley   +1 more source

A Novel W1999S Mutation and Non-Target Site Resistance Impact on Acetyl-CoA Carboxylase Inhibiting Herbicides to Varying Degrees in a UK Lolium multiflorum Population

, 2013
Shiv Shankhar Kaundun, Géraldine Bailly, Richard P. Dale, Sarah‐Jane Hutchings, Eddie Mcindoe   +4 more
openalex   +2 more sources

Ketogenic Nutrition in Combination With PPARα Activation Induced Metabolic Failure and Exacerbated Muscle Weakness in Septic Mice

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 6, December 2025.
ABSTRACT Background Suppression of the peroxisome proliferator‐activated receptor alpha (PPARα) has been related to poor outcomes in sepsis and may compromise ketogenesis during critical illness. Infusion of 3‐hydroxybutyrate (3HB) was shown to attenuate muscle weakness in septic mice.
Caroline Lauwers, Wouter Vankrunkelsven, Sarah Derde, Sarah Vander Perre, Inge Derese, Lies Pauwels, Ilse Vanhorebeek, Louis Libbrecht, Pieter Vermeersch, Jan Gunst, Greet Van den Berghe, Michael P. Casaer, Lies Langouche   +12 more
wiley   +1 more source

Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway. [PDF]

MedComm (2020)
Lai J, Liu S, Chen Y, Chen J, Li J, Liang Z, Mei X, Feng Y, Han Z, Jiang F, Yang S, Wu Y, Tan H, Liu J, He H, Zhong W.   +15 more
europepmc   +1 more source

Biotinoyl Domain of Human Acetyl-CoA Carboxylase;Structural Insights into the Carboxyl Transfer Mechanism [PDF]

, 2008
Chung-Kyung Lee, Hae‐Kap Cheong, Kyoung‐Seok Ryu, Jae‐Il Lee, Young-Ho Jeon, C.G. Cheong   +5 more
openalex   +1 more source

Dynamic Evolution of the Tumor Immune Microenvironment in Malignant Tumors and Emerging Therapeutic Paradigms

MedComm, Volume 6, Issue 12, December 2025.
Cancer is a complex tumor system consisting of tumor cells, immune effector cells, and all the matrix components. The intricate interactions among cells and molecular signaling pathways in this microenvironment jointly drive tumor growth, invasion, and metastasis, and significantly influence the efficacy of cancer treatment. Meanwhile, the treatment of
Ying Sun, Changjian Shao, Hongtao Duan, Zhaoyang Wang, Shaopeng Xu, Chao Wang, Jiawei Xiu, Jin Liu, Xuejiao Wang, Xin Yao, Yuan Gao, Xiaolong Yan   +11 more
wiley   +1 more source

Regulation of human Th9 cell differentiation by lipid modulators targeting PPAR-γ and acetyl-CoA-carboxylase 1. [PDF]

Front Immunol
Peesari S, McAleer JP.
europepmc   +1 more source

Differential regulation of the yeast isozymes of pyruvate carboxylase and the locus of action of acetyl CoA

, 2007
Sarawut Jitrapakdee, Abdussalam Adina-Zada, Paul G. Besant, Kathy H. Surinya, W. W. Cleland, John C. Wallace, Paul V. Attwood   +6 more
openalex   +1 more source

Alcohol‐Related Liver Disease and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Molecular Pathogenesis and Therapeutic Interventions

MedComm, Volume 6, Issue 12, December 2025.
Alcohol‐related (ALD) and metabolic dysfunction‐associated (MASLD) steatotic liver disease, while initiated by distinct etiologies (ethanol vs. metabolic stress), converge on shared core pathogenic pathways that drive progression. These include dysregulated lipid metabolism, programmed cell death, cellular senescence, gut dysbiosis, and immune ...
Yupin Tan, Yirui Hu, Ye Yang, Huikuan Chu   +3 more
wiley   +1 more source